Alnylam Pharmaceuticals, Inc.'s Net Worth

Alnylam Pharmaceuticals, Inc.'s net worth is estimated to be at least $9,148,512.68 as of 11/25/2024. CoreStreet's estimation of Alnylam Pharmaceuticals, Inc.'s net worth is based on their sale of stock and current holding of stock.

Alnylam Pharmaceuticals, Inc. is Major Shareholder at Regulus Therapeutics Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,000,000 units of RGLS stock on 02/23/2016. Their biggest sale was on 02/23/2016 when they sold 1,000,000 units of Regulus Therapeutics Inc stock for $7,180,000.00. They typically trade 7 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $9,148,512.68
Most recent insider trade:
  • Feb. 23, 2016

Alnylam Pharmaceuticals, Inc.'s Insider Trading History

Regulus Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 23, 2016
Major Shareholder1,000,000$7.18Sell$7,180,000.00
Oct. 24, 2014
Major Shareholder113,084$14.02Sell$1,585,437.68
Oct. 10, 2014
Major Shareholder2,000$6.41Sell$12,820.00
Oct. 3, 2014
Major Shareholder10,300$6.74Sell$69,422.00
Sept. 26, 2014
Major Shareholder2,500$7.04Sell$17,600.00
Sept. 25, 2014
Major Shareholder2,500$7.12Sell$17,800.00
Sept. 24, 2014
Major Shareholder3,750$7.19Sell$26,962.50
Sept. 19, 2014
Major Shareholder7,700$7.31Sell$56,287.00
Sept. 12, 2014
Major Shareholder8,900$7.85Sell$69,865.00
Aug. 22, 2014
Major Shareholder5,250$6.75Sell$35,437.50
Aug. 21, 2014
Major Shareholder2,500$6.89Sell$17,225.00
Aug. 20, 2014
Major Shareholder3,000$7.14Sell$21,420.00
Aug. 15, 2014
Major Shareholder1,450$6.98Sell$10,121.00
Aug. 14, 2014
Major Shareholder1,750$7.04Sell$12,320.00
Aug. 13, 2014
Major Shareholder2,250$7.02Sell$15,795.00